Home/Panbela Therapeutics/Jennifer K. Simpson
JK

Jennifer K. Simpson

President, CEO & Director

Panbela Therapeutics

Therapeutic Areas

Panbela Therapeutics Pipeline

DrugIndicationPhase
Ivospemin (SBP-101)Metastatic Pancreatic Ductal AdenocarcinomaPhase 3
Flynpovi™ (CPP-1X/sulindac)Familial Adenomatous Polyposis (FAP)Phase 3
SBP-101 (Ivospemin)Other Solid TumorsResearch